Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors

[1]  A. Ashworth,et al.  Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.

[2]  J. Gautier,et al.  PIKK-dependent phosphorylation of Mre11 induces MRN complex inactivation by disassembly from chromatin. , 2009, DNA repair.

[3]  R. Tuma.  PARP inhibitors: will the new class of drugs match the hype? , 2009, Journal of the National Cancer Institute.

[4]  J. Gautier,et al.  Checkpoint signaling from a single DNA interstrand crosslink. , 2009, Molecular cell.

[5]  Hans Joenje,et al.  The genetic and molecular basis of Fanconi anemia. , 2009, Mutation research.

[6]  I. Landais,et al.  The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways* , 2009, The Journal of Biological Chemistry.

[7]  Michael J. Emanuele,et al.  A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene , 2009, Cell.

[8]  Sridhar Ramaswamy,et al.  Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells , 2009, Cell.

[9]  I. Landais,et al.  A novel cell‐free screen identifies a potent inhibitor of the Fanconi anemia pathway , 2009, International journal of cancer.

[10]  J. Gautier,et al.  Fanconi anemia proteins stabilize replication forks. , 2008, DNA repair.

[11]  S. Elledge,et al.  FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway , 2008, Nature Structural &Molecular Biology.

[12]  L. Lai,et al.  Finding multiple target optimal intervention in disease-related molecular network , 2008, Molecular systems biology.

[13]  M. Lavin,et al.  Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer , 2008, Nature Reviews Molecular Cell Biology.

[14]  J. Snyder,et al.  Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin , 2008, Molecular Pharmacology.

[15]  J. Snyder,et al.  EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1 , 2008, Cell cycle.

[16]  Alan Ashworth,et al.  A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  I. Gülçin,et al.  Antioxidant and radical scavenging properties of curcumin. , 2008, Chemico-biological interactions.

[18]  J. Snyder,et al.  Radiosensitization of glioma cells with the curcumin analogs EF24 and EF31 , 2008 .

[19]  Jean Gautier,et al.  A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. , 2008, Nature chemical biology.

[20]  J. Snyder,et al.  Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa , 2008 .

[21]  R. Siebert,et al.  Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Weidong Wang.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins , 2007, Nature Reviews Genetics.

[23]  T. Taniguchi,et al.  Proteasome function is required for DNA damage response and fanconi anemia pathway activation. , 2007, Cancer research.

[24]  Akiko Shimamura,et al.  Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. , 2007, The Journal of clinical investigation.

[25]  N. Rahman,et al.  Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players. , 2007, Human molecular genetics.

[26]  M. Hoatlin,et al.  DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein FANCD2 , 2007, Molecular and Cellular Biology.

[27]  G. Peng,et al.  DNA damage response: the players, the network and the role in tumor suppression. , 2007, Cancer Genomics & Proteomics.

[28]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[29]  C. Brancolini,et al.  Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. , 2006, Cancer research.

[30]  A. D’Andrea,et al.  Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance , 2006, Molecular and Cellular Biology.

[31]  J. Snyder,et al.  Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. , 2006, Journal of medicinal chemistry.

[32]  A. Gurtan,et al.  The WD40 Repeats of FANCL Are Required for Fanconi Anemia Core Complex Assembly* , 2006, Journal of Biological Chemistry.

[33]  A. D’Andrea,et al.  Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway , 2006, Molecular Cancer Therapeutics.

[34]  Weidong Wang,et al.  Fanconi Anemia Proteins Are Required To Prevent Accumulation of Replication-Associated DNA Double-Strand Breaks , 2006, Molecular and Cellular Biology.

[35]  Dean P. Jones,et al.  EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism , 2005, Anti-cancer drugs.

[36]  J. Snyder,et al.  Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. , 2004, Bioorganic & medicinal chemistry.

[37]  N. Nukina,et al.  Inhibition of Proteasomal Function by Curcumin Induces Apoptosis through Mitochondrial Pathway* , 2004, Journal of Biological Chemistry.

[38]  W. Chan,et al.  Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  James R. Burke,et al.  BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice* , 2003, The Journal of Biological Chemistry.

[40]  A. D’Andrea,et al.  S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. , 2002, Blood.

[41]  K. Cimprich,et al.  A requirement for replication in activation of the ATR-dependent DNA damage checkpoint. , 2002, Genes & development.

[42]  G. Chintalwar,et al.  Protective Activities of Some Phenolic 1,3‐Diketones against Lipid Peroxidation: Possible Involvement of the 1,3‐Diketone Moiety , 2002, Chembiochem : a European journal of chemical biology.

[43]  T. Pandita,et al.  Spontaneously immortalized cell lines obtained from adult Atm null mice retain sensitivity to ionizing radiation and exhibit a mutational pattern suggestive of oxidative stress , 2001, Oncogene.

[44]  M. Bibikova,et al.  Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. , 2001, Molecular cell.

[45]  W. Brownell,et al.  Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. , 2000, Genes & development.

[46]  S. Elledge,et al.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. , 2000, Genes & development.

[47]  E. Wagner,et al.  PARP is important for genomic stability but dispensable in apoptosis. , 1997, Genes & development.

[48]  K. Chrzanowska,et al.  Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair , 2010, Journal of Applied Genetics.

[49]  J. Snyder,et al.  Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa. , 2008, Journal of drug targeting.

[50]  B. Aggarwal,et al.  Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.

[51]  H. Hoehn,et al.  Fanconi anemia: causes and consequences of genetic instability. , 2006, Genome dynamics.

[52]  K. McIntyre,et al.  BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. , 2003, The Journal of biological chemistry.

[53]  A. Manning,et al.  Fanconi anemia protein complex is a novel target of the IKK signalsome , 2002, Journal of cellular biochemistry.

[54]  M. Buchwald,et al.  Identification of two complementation groups in Fanconi anemia , 1985, Somatic cell and molecular genetics.